AOC3 and arthritic joint disease: In arthritis models, mice lacking VAP-1 showed attenuation of anti-collagen antibody-induced arthritis [15] and administration of VAP-1 inhibitors reduced clinical inflammation scores and disease progression (adjuvant-induced anti-type II collagen antibody-induced arthritis, and several other models of chronic arthritis) [15,16,17].